Industry resources and insights

Sort by year
  • All time
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017 and older
Insider Insights
More clarity given on the proposed changes to comb...

The German government has released information regarding the 20% discounts to combination products e...

Read more
PMA Insights: Week 11

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
Newly agreed Windsor Framework carries significant...

Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...

Read more
Insider Insights
What has occurred in the past year in the Swedish ...

TLV unveils annual report, offering insights into trends and projects that have dominated the past y...

Read more
Insider Insights
Government announces new action plan for rare dise...

Hope that new action plan and collaboration with the rare diseases community will progress positive ...

Read more
Insider Insights
The Financial Stabilisation Act is unlikely to off...

DAK-Gesundheit claim that cost saving measures imposed by the GVK Financial Stabilisation Act are un...

Read more
Load more
Browse by topic
  • Biosimilars
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • Launch
  • Managed Entry Agreements
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
Content type
  • All
  • Articles
  • Case Study
  • Insider Insights
  • News
  • Newsletter
  • Publications
  • Webinar
This field is for validation purposes and should be left unchanged.